Case File №
#VI-2026-0545
Rayshine Peptide Biochemicals
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
36 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | C Okay | 6 | 7.7 | 4.4 | 10.0 | 12 Aug 2025 |
| 4-Anilinopiperidine CAS 99918-43-1 | X N/A | 1 | 5.6 | 5.6 | 5.6 | 13 Feb 2025 |
| ACE-031 | X N/A | 1 | 6.4 | 6.4 | 6.4 | 8 Jul 2025 |
| Adipotide | X N/A | 1 | 7.0 | 7.0 | 7.0 | 3 Jun 2025 |
| Cerebrolysin | X N/A | 1 | 6.9 | 6.9 | 6.9 | 11 Jun 2025 |
| Chonluten | X N/A | 1 | 6.7 | 6.7 | 6.7 | 17 Dec 2024 |
| DHB (1-Test Cyp) | X N/A | 1 | 6.1 | 6.1 | 6.1 | 27 Feb 2025 |
| Epithalon | X N/A | 1 | 5.3 | 5.3 | 5.3 | 14 Jan 2025 |
| EPO | X N/A | 1 | 10.0 | 10.0 | 10.0 | 3 Jun 2025 |
| GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | X N/A | 1 | 7.3 | 7.3 | 7.3 | 16 Mar 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 7.2 | 7.2 | 7.2 | 9 Jun 2025 |
| Hexarelin | X N/A | 1 | 6.8 | 6.8 | 6.8 | 3 Jul 2025 |
| IGF-1 LR3 | X N/A | 1 | 8.8 | 8.8 | 8.8 | 21 May 2025 |
| Ivermectin | X N/A | 1 | 8.5 | 8.5 | 8.5 | 17 Dec 2024 |
| KissPeptin-10 | X N/A | 1 | 6.9 | 6.9 | 6.9 | 14 Jan 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 7.6 | 7.6 | 7.6 | 16 Mar 2025 |
| Lipo-C FOCUS 425mg | X N/A | 1 | 8.6 | 8.6 | 8.6 | 13 Jun 2025 |
| Masteron P (Drostanolone P) | X N/A | 1 | 8.1 | 8.1 | 8.1 | 3 Jun 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 8.4 | 8.4 | 8.4 | 24 Apr 2025 |
| Oxytocin Acetate | X N/A | 1 | 6.6 | 6.6 | 6.6 | 6 May 2025 |
| PE 22-28 | X N/A | 1 | 6.5 | 6.5 | 6.5 | 28 Mar 2025 |
| PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | X N/A | 1 | 5.7 | 5.7 | 5.7 | 17 Dec 2024 |
| Prostamax | X N/A | 1 | 8.0 | 8.0 | 8.0 | 13 Jun 2025 |
| PTD-DBM | X N/A | 1 | 8.7 | 8.7 | 8.7 | 9 Jun 2025 |
| Romosozumab | X N/A | 1 | 9.3 | 9.3 | 9.3 | 2 Apr 2025 |
| S-23 Raw | X N/A | 1 | 7.2 | 7.2 | 7.2 | 27 Feb 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 8.1 | 8.1 | 8.1 | 20 Jun 2025 |
| Sildenafil Raw | X N/A | 1 | 6.3 | 6.3 | 6.3 | 27 Feb 2025 |
| Superdrol | X N/A | 1 | 8.0 | 8.0 | 8.0 | 11 Jun 2025 |
| Teriparatide | X N/A | 1 | 7.4 | 7.4 | 7.4 | 24 Apr 2025 |
| Test Base (No Ester) | X N/A | 1 | 7.8 | 7.8 | 7.8 | 27 Feb 2025 |
| Thymosin Alpha-1 | X N/A | 1 | 9.7 | 9.7 | 9.7 | 3 Jun 2025 |
| Vitamin B12 1mg/ml | X N/A | 1 | 8.7 | 8.7 | 8.7 | 2 Apr 2025 |
| Winstrol Oil | X N/A | 1 | 4.9 | 4.9 | 4.9 | 25 Apr 2025 |
| Winstrol (Stanozolol) | X N/A | 1 | 7.4 | 7.4 | 7.4 | 11 Jun 2025 |
| Winstrol Water (Stanozolol) | X N/A | 1 | 6.4 | 6.4 | 6.4 | 3 Jun 2025 |
Exhibit II
Evidence Log
41 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | Adipotide | 8.5 A | 50mg | 56.8mg | +13.6% | 98.32% | mlwces | Lab E | Public |
| 24 May 2026 | Sildenafil Raw | 7.3 A | 1g | 1.1g | +10.8% | 97.70% | 8a0b0i | Lab G | Public |
| 24 May 2026 | Teriparatide | 9.8 A | 30mg | 29.9mg | -0.3% | 99.15% | onxpeo | Lab G | Community |
| 24 May 2026 | Test Base (No Ester) | 9.0 A | 200mg/ml | 237.9mg/ml | +18.9% | 98.68% | c59ad5 | Lab A | Community |
| 24 May 2026 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 8.7 A | 50mg | 43.1mg | -13.8% | 99.10% | 5hf4qn | Lab D | Public |
| 23 May 2026 | Ivermectin | 8.4 A | 25mg | 24.0mg | -4.0% | 95.79% | nfnq0a | Lab A | Public |
| 23 May 2026 | Winstrol Oil | 4.0 C | 250mg/ml | 285.6mg/ml | +14.2% | 95.52% | nci8hm | Lab A | Community |
| 23 May 2026 | Hexarelin | 5.4 B | 30mg | 34.7mg | +15.8% | 96.10% | ym7q24 | Lab F | Community |
| 23 May 2026 | Superdrol | 8.6 A | 10mg | 11.6mg | +15.8% | 96.05% | 3iqvng | Lab G | Public |
| 21 May 2026 | Selank 10mg + Semax 10mg Blend | 9.8 A | 50mg | 60.6mg | +21.2% | 95.35% | tbhhjy | Lab G | Community |
| 20 May 2026 | Chonluten | 6.5 A | 10mg | 12.0mg | +20.2% | 98.35% | vkzbfb | Lab B | Public |
| 20 May 2026 | S-23 Raw | 6.6 A | 500g | 617.7g | +23.5% | 97.85% | zelc96 | Lab G | Public |
| 20 May 2026 | Winstrol (Stanozolol) | 7.0 A | 50mg | 56.0mg | +12.1% | 95.13% | b61psm | Lab B | Community |
| 17 May 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 4.5 C | 500g | 580.5g | +16.1% | 99.49% | uneshp | Lab D | Public |
| 26 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 7.6 A | 20mg | 20.4mg | +2.2% | 97.90% | 8ldrox | Lab D | Community |
| 26 Jan 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 10.0 A | 5mg | 4.8mg | -4.8% | 97.28% | yryfsc | Lab D | Community |
| 19 Jan 2026 | Retatrutide | 4.4 D | 5mg | 8.41mg | +68.2% | 99.95% | (no batch ID) | Lab E | Public |
| 19 Jan 2026 | Winstrol Water (Stanozolol) | 6.3 A | 200mg/ml | 219.0mg/ml | +9.5% | 97.90% | 176t1q | Lab A | Community |
| 9 Jan 2026 | Cerebrolysin | 6.7 A | 10mg | 11.5mg | +15.1% | 99.17% | 5srtbg | Lab D | Public |
| 9 Jan 2026 | EPO | 9.4 A | 2mg | 2.5mg | +24.7% | 96.76% | nnved3 | Lab B | Public |
| 7 Jan 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 5.1 B | 100g | 106.9g | +6.9% | 98.79% | 51uafi | Lab D | Public |
| 6 Jan 2026 | Epithalon | 6.2 A | 50mg | 51.0mg | +2.0% | 95.78% | 7nxkko | Lab E | Community |
| 29 Dec 2025 | Masteron P (Drostanolone P) | 7.8 A | 300mg/ml | 347.1mg/ml | +15.7% | 95.63% | qfxzf5 | Lab F | Community |
| 12 Dec 2025 | Thymosin Alpha-1 | 9.8 A | 20mg | 17.3mg | -13.5% | 96.99% | 3vm07j | Lab E | Public |
| 12 Dec 2025 | Vitamin B12 1mg/ml | 7.9 A | 300mg/ml | 305.4mg/ml | +1.8% | 98.60% | rrtm9r | Lab D | Public |
| 23 Nov 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.2 A | 10mg | 12.1mg | +20.8% | 96.16% | hh3hv1 | Lab A | Community |
| 17 Nov 2025 | Oxytocin Acetate | 4.6 C | 2mg | 2.0mg | +2.2% | 95.32% | 1avrth | Lab G | Community |
| 14 Nov 2025 | PE 22-28 | 7.2 A | 15mg | 17.0mg | +13.2% | 99.26% | gnw6vv | Lab D | Community |
| 5 Nov 2025 | KissPeptin-10 | 7.7 A | 50mg | 45.7mg | -8.7% | 97.67% | 8ciklh | Lab C | Community |
| 4 Nov 2025 | DHB (1-Test Cyp) | 6.3 A | 200mg/ml | 224.9mg/ml | +12.4% | 95.13% | ljaiob | Lab E | Community |
| 9 Oct 2025 | IGF-1 LR3 | 8.3 A | 10mg | 10.1mg | +0.7% | 98.02% | par5jy | Lab F | Public |
| 9 Oct 2025 | PTD-DBM | 8.3 A | 5mg | 5.6mg | +11.7% | 97.39% | yei8b3 | Lab F | Public |
| 5 Oct 2025 | Retatrutide | 10.0 A | 20mg | 19.6mg | -2.0% | 99.92% | July 15,2025 | Lab E | Public |
| 5 Oct 2025 | Retatrutide | 9.5 A | 30mg | 30.8mg | +2.7% | 99.72% | July 15, 2025 | Lab E | Public |
| 5 Oct 2025 | Retatrutide | 9.5 A | 30mg | 28.8mg | -4.0% | 99.70% | July 15, 2025 | Lab E | Public |
| 3 Oct 2025 | Retatrutide | 7.5 A | 5mg | 5.27mg | +5.4% | 99.76% | (no batch ID) | Lab E | Public |
| 3 Oct 2025 | ACE-031 | 6.3 A | 15mg | 18.2mg | +21.2% | 98.51% | g4a16v | Lab G | Public |
| 3 Oct 2025 | Lipo-C FOCUS 425mg | 8.9 A | 200mg/ml | 215.1mg/ml | +7.5% | 99.51% | bmagzx | Lab D | Community |
| 3 Oct 2025 | Prostamax | 8.8 A | 2mg | 2.1mg | +3.1% | 98.45% | lqd48g | Lab D | Public |
| 3 Oct 2025 | Romosozumab | 10.0 A | 2mg | 2.0mg | +0.5% | 98.58% | 8jrtt1 | Lab B | Community |
| 12 Aug 2025 | Retatrutide | 5.5 C | 20mg | 21.85mg | +9.3% | 99.41% | (no batch ID) | Lab A | Public |
— END OF EVIDENCE LOG —